Cargando…
Advancing Cancer Therapy with Copper/Disulfiram Nanomedicines and Drug Delivery Systems
Disulfiram (DSF) is a thiocarbamate based drug that has been approved for treating alcoholism for over 60 years. Preclinical studies have shown that DSF has anticancer efficacy, and its supplementation with copper (CuII) significantly potentiates the efficacy of DSF. However, the results of clinical...
Autores principales: | Kang, Xuejia, Jadhav, Sanika, Annaji, Manjusha, Huang, Chung-Hui, Amin, Rajesh, Shen, Jianzhong, Ashby, Charles R., Tiwari, Amit K., Babu, R. Jayachandra, Chen, Pengyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302862/ https://www.ncbi.nlm.nih.gov/pubmed/37376016 http://dx.doi.org/10.3390/pharmaceutics15061567 |
Ejemplares similares
-
Liposomal DQ in Combination with Copper Inhibits ARID1A Mutant Ovarian Cancer Growth
por: Kang, Xuejia, et al.
Publicado: (2023) -
Resveratrol‐loaded nanomedicines for cancer applications
por: Annaji, Manjusha, et al.
Publicado: (2021) -
Exploring the Application of Micellar Drug Delivery Systems in Cancer Nanomedicine
por: Wang, Qi, et al.
Publicado: (2023) -
pH-Sensitive Liposomes for Enhanced Cellular Uptake and Cytotoxicity of Daunorubicin in Melanoma (B16-BL6) Cell Lines
por: Alrbyawi, Hamad, et al.
Publicado: (2022) -
Topical Delivery of Diacetyl Boldine in a Microemulsion Formulation for Chemoprotection against Melanoma
por: Al Saqr, Ahmed, et al.
Publicado: (2023)